rs7996253

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_207361.6(FREM2):​c.8885C>T​(p.Ala2962Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00344 in 1,614,096 control chromosomes in the GnomAD database, including 183 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A2962A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.019 ( 105 hom., cov: 33)
Exomes 𝑓: 0.0018 ( 78 hom. )

Consequence

FREM2
NM_207361.6 missense

Scores

3
12

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 3.19

Publications

5 publications found
Variant links:
Genes affected
FREM2 (HGNC:25396): (FRAS1 related extracellular matrix 2) This gene encodes an integral membrane protein containing numerous CSPG (chondroitin sulfate proteoglycan element) repeats and Calx-beta domains. The encoded protein localizes to the basement membrane, forming a ternary complex that plays a role in epidermal-dermal interactions. This protein is important for the integrity of skin and renal epithelia. Mutations in this gene are associated with Fraser syndrome. [provided by RefSeq, Apr 2014]
FREM2 Gene-Disease associations (from GenCC):
  • Fraser syndrome 2
    Inheritance: AR Classification: DEFINITIVE, MODERATE Submitted by: G2P, Ambry Genetics
  • Fraser syndrome 1
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • renal agenesis, unilateral
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Fraser syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0034364462).
BP6
Variant 13-38878856-C-T is Benign according to our data. Variant chr13-38878856-C-T is described in ClinVar as Benign. ClinVar VariationId is 235742.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.064 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FREM2NM_207361.6 linkc.8885C>T p.Ala2962Val missense_variant Exon 23 of 24 ENST00000280481.9 NP_997244.4 Q5SZK8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FREM2ENST00000280481.9 linkc.8885C>T p.Ala2962Val missense_variant Exon 23 of 24 1 NM_207361.6 ENSP00000280481.7 Q5SZK8-1

Frequencies

GnomAD3 genomes
AF:
0.0186
AC:
2834
AN:
152160
Hom.:
106
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0660
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00471
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00908
GnomAD2 exomes
AF:
0.00475
AC:
1194
AN:
251424
AF XY:
0.00332
show subpopulations
Gnomad AFR exome
AF:
0.0658
Gnomad AMR exome
AF:
0.00289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000616
Gnomad OTH exome
AF:
0.00130
GnomAD4 exome
AF:
0.00185
AC:
2702
AN:
1461818
Hom.:
78
Cov.:
33
AF XY:
0.00157
AC XY:
1145
AN XY:
727218
show subpopulations
African (AFR)
AF:
0.0664
AC:
2222
AN:
33476
American (AMR)
AF:
0.00277
AC:
124
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.000220
AC:
19
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.00277
AC:
16
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000710
AC:
79
AN:
1111950
Other (OTH)
AF:
0.00401
AC:
242
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
141
282
422
563
704
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
72
144
216
288
360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0187
AC:
2844
AN:
152278
Hom.:
105
Cov.:
33
AF XY:
0.0184
AC XY:
1369
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.0660
AC:
2743
AN:
41552
American (AMR)
AF:
0.00471
AC:
72
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68026
Other (OTH)
AF:
0.00899
AC:
19
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
136
272
408
544
680
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00716
Hom.:
89
Bravo
AF:
0.0208
ESP6500AA
AF:
0.0660
AC:
291
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00597
AC:
725
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.000382
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 12, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 19, 2015
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Fraser syndrome 2 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
20
DANN
Uncertain
0.99
Eigen
Benign
0.11
Eigen_PC
Benign
0.13
FATHMM_MKL
Uncertain
0.94
D
MetaRNN
Benign
0.0034
T
MetaSVM
Benign
-1.1
T
PhyloP100
3.2
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
-1.9
N
REVEL
Benign
0.11
Sift
Benign
0.16
T
Sift4G
Benign
0.27
T
Vest4
0.24
MVP
0.64
MPC
0.12
ClinPred
0.021
T
GERP RS
2.8
gMVP
0.34
Mutation Taster
=91/9
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7996253; hg19: chr13-39452993; API